Screening of herbal medicines from China with inhibitory activity on advanced glycation end products formation (XIII)
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Choi, S.J. | - |
dc.contributor.author | Kim, Y.S. | - |
dc.contributor.author | Kim, J.H. | - |
dc.contributor.author | Hang, S. | - |
dc.contributor.author | Kim, J.S. | - |
dc.date.available | 2020-02-28T10:45:24Z | - |
dc.date.created | 2020-02-12 | - |
dc.date.issued | 2015-09 | - |
dc.identifier.issn | 0253-3073 | - |
dc.identifier.uri | https://scholarworks.bwise.kr/gachon/handle/2020.sw.gachon/10943 | - |
dc.description.abstract | Advanced glycation end products (AGEs) have been postulated to play a central role in the development of diabetic complications. A variety of different agents that inhibit AGEs have been under investigation. In this study, 111 herbal medicines from China have been investigated with an in vitro evaluation system using AGEs formation inhibitory activity. Of these, 9 herbal medicines (IC50: <5 μg/ml) were found to have significant AGEs formation inhibitory activity. Particularly, herbal medicines Barleria cristata (leaves), Calotropis gigantea (stems), Ardisia virens (leaves), Dalbergia yunnanensis (leaves) Pittosporum runcatum (leaves), Ardisia japonica (leaves), Rhododendron racemosum (twigs), Oxyria sinensiss (aerial parts), Pyrrosia calvata (whole plants), showed more potent inhibitory activity (approximately 15-40 fold) than the positive control aminoguanidine (IC50: 76.47 μg/ml). © 2015, Korean Society of Pharmacognosy. All rights reserved. | - |
dc.language | 한국어 | - |
dc.language.iso | ko | - |
dc.publisher | Korean Society of Pharmacognosy | - |
dc.relation.isPartOf | Korean Journal of Pharmacognosy | - |
dc.title | Screening of herbal medicines from China with inhibitory activity on advanced glycation end products formation (XIII) | - |
dc.title.alternative | 중국 약용식물의 최종당화산물 생성저해활성 검색(XIII) | - |
dc.type | Article | - |
dc.type.rims | ART | - |
dc.description.journalClass | 1 | - |
dc.identifier.bibliographicCitation | Korean Journal of Pharmacognosy, v.46, no.3, pp.260 - 267 | - |
dc.identifier.kciid | ART002032689 | - |
dc.description.isOpenAccess | N | - |
dc.identifier.scopusid | 2-s2.0-84944040245 | - |
dc.citation.endPage | 267 | - |
dc.citation.startPage | 260 | - |
dc.citation.title | Korean Journal of Pharmacognosy | - |
dc.citation.volume | 46 | - |
dc.citation.number | 3 | - |
dc.contributor.affiliatedAuthor | Kim, J.H. | - |
dc.type.docType | Article | - |
dc.subject.keywordAuthor | Advanced glycation end products (AGEs) | - |
dc.subject.keywordAuthor | Diabetic complications | - |
dc.subject.keywordAuthor | Herbal medicines | - |
dc.subject.keywordPlus | advanced glycation end product | - |
dc.subject.keywordPlus | aminoguanidine | - |
dc.subject.keywordPlus | herbaceous agent | - |
dc.subject.keywordPlus | Ardisia japonica | - |
dc.subject.keywordPlus | Ardisia virens | - |
dc.subject.keywordPlus | Article | - |
dc.subject.keywordPlus | Barleria cristata | - |
dc.subject.keywordPlus | Calotropis gigantea | - |
dc.subject.keywordPlus | China | - |
dc.subject.keywordPlus | controlled study | - |
dc.subject.keywordPlus | Dalbergia yunnanensis | - |
dc.subject.keywordPlus | drug screening | - |
dc.subject.keywordPlus | herbal medicine | - |
dc.subject.keywordPlus | IC50 | - |
dc.subject.keywordPlus | medicinal plant | - |
dc.subject.keywordPlus | nonhuman | - |
dc.subject.keywordPlus | Oxyria sinensis | - |
dc.subject.keywordPlus | Pittosporum truncatum | - |
dc.subject.keywordPlus | plant leaf | - |
dc.subject.keywordPlus | Pyrrosia calvata | - |
dc.subject.keywordPlus | Rhododendron racemosum | - |
dc.description.journalRegisteredClass | scopus | - |
dc.description.journalRegisteredClass | kci | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
1342, Seongnam-daero, Sujeong-gu, Seongnam-si, Gyeonggi-do, Republic of Korea(13120)031-750-5114
COPYRIGHT 2020 Gachon University All Rights Reserved.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.